Fermenta Biotech reported Q1FY27 profit after tax of Rs 9.5 crore. The company highlighted 18% sequential volume growth in its Human Nutrition segment, while facing headwinds in Animal Nutrition.
Fermenta Biotech Reports Q1FY27 Results
Fermenta Biotech's Profit after Tax (PAT) for Q1FY27 stood at Rs 9.5 crore, with Revenue at Rs 126.2 crore. Reader Takeaway: Human Nutrition volumes grow sequentially, but Animal Nutrition faces headwinds and subsidiaries report losses. ## What just happened Fermenta Biotech announced its Q1FY27 financial results, posting a Profit after Tax (PAT) of Rs 9.5 crore on revenues of Rs 126.2 crore. EBITDA was Rs 22.4 crore, and diluted Earnings Per Share (EPS) was Rs 3.34. ## Why this matters The results indicate a mixed performance. While the Human Nutrition segment showed strong sequential volume growth of 18%, the Animal Nutrition segment experienced declines and lower realizations. Management described the quarter as a "building" phase, with year-on-year comparisons affected by a strong prior-year base that included non-recurring items. ## The backstory Management noted that Q1FY26 had an exceptionally strong base due to non-recurring items like insurance income and real estate value unlocking. The company's focus remains on long-term capacity utilization and volume growth across its businesses. ## What changes now Fermenta Biotech is concentrating on scaling its Human Nutrition business and acquiring customers in Green Chemistry and Other APIs. The company is prioritizing volume discipline in Animal Nutrition despite structural headwinds. A significant development post-quarter is the FSSAI approval for VITADEE Green (plant-source Vitamin D3), creating new opportunities. ## Risks to watch Key concerns include the sustained weakness in the Animal Nutrition segment, ongoing EBITDA losses from its German, US trading, and Environment subsidiaries, and the interpretation of year-on-year figures due to the high base effect in Q1FY26. ## Peer comparison This filing does not provide direct peer comparison data. ## Context metrics (time-bound) * Revenue (incl. real estate): Rs 126.2 crore in Q1FY27. * EBITDA (incl. real estate): Rs 22.4 crore in Q1FY27. * Profit after tax (PAT): Rs 9.5 crore in Q1FY27. * EPS (diluted): Rs 3.34 in Q1FY27. * Human Nutrition volume growth: 18% quarter-on-quarter. * India's revenue contribution: 47% in Q1FY27 (up from 35% YoY). * German Subsidiary EBITDA loss: INR 0.8 crore. * US Trading Subsidiary EBITDA loss: INR 0.7 crore. * Environment Subsidiary EBITDA loss: INR 2.9 crore. ## What to track next Investors will be watching the performance of the Animal Nutrition segment, the turnaround of loss-making subsidiaries, and the market uptake of VITADEE Green in India.
